Your shopping cart is currently empty

WAY-100635 is a potent 5-HT 1A receptor antagonist with an IC50 = 0.91 nM that abrogates the reduction in hippocampal CA1 pyramidal neuron firing frequency during conditioned reflexes; it also acts as a dopamine D4 receptor agonist with an affinity of 3.3 nM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $36 | - | In Stock | |
| 5 mg | $57 | - | In Stock | |
| 10 mg | $97 | - | In Stock | |
| 25 mg | $183 | - | In Stock | |
| 50 mg | $272 | - | In Stock | |
| 100 mg | $393 | 7-10 days | 7-10 days | |
| 1 mL x 10 mM (in DMSO) | $63 | - | In Stock |
| Description | WAY-100635 is a potent 5-HT 1A receptor antagonist with an IC50 = 0.91 nM that abrogates the reduction in hippocampal CA1 pyramidal neuron firing frequency during conditioned reflexes; it also acts as a dopamine D4 receptor agonist with an affinity of 3.3 nM. |
| Targets&IC50 | 5-HT1A receptor:8.87 (pIC50), 5-HT1A receptor:9.71 (pA2) |
| In vitro | The functional properties and binding affinities of WAY-100635 are evaluated in HEK 293 cells stably expressing dopamine D 2L or D 4.4 receptors [1]. WAY-100635 has binding affinities of 940, 370, and 16 nM on D 2L, D 3, and D 4.2 receptors, respectively. Saturation analyses shows that the K d of [ 3 H] WAY-100635 at D 4.2 receptors is 2.4 nM. WAY-100635 is potent agonist in HEK-D 4.4 cells with EC 50 of 9.7 nM. WAY-100635 possesses high affinity for D 4.4 receptor (3.3 nM) [1]. |
| In vivo | Treatment with WAY-100635 (1 mg/kg; subcutaneous injection; male Sprague-Dawley rats) abolishes the reduction of the severity of abstinence signs induced by Rhodiola rosea administration in nicotine-dependent rat [2]. Animal Model: Male Sprague-Dawley rats (220-240 g) [2] Dosage: 1 mg/kg Administration: Subcutaneous injection (Pharmacokinetic study) Result: Reduced total abstinence score, increased immobility time and the burying behavior was increased. |
| Synonyms | WAY100635 |
| Molecular Weight | 422.56 |
| Formula | C25H34N4O2 |
| Cas No. | 162760-96-5 |
| Smiles | O=C(N(C1=NC=CC=C1)CCN2CCN(C=3C=CC=CC3OC)CC2)C4CCCCC4 |
| Relative Density. | 1.154 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (118.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.73 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.